{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:37:45Z","timestamp":1792201065534,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2377-8-29","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T18:13:31Z","timestamp":1217614411000},"source":"Crossref","is-referenced-by-count":233,"title":["Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials"],"prefix":"10.1186","volume":"8","author":[{"given":"Asquad","family":"Sultan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Gaskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,1]]},"reference":[{"key":"191_CR1","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","volume":"68","author":"MP Jensen","year":"2007","unstructured":"Jensen MP, Chodroff MJ, Dworkin RH: The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007, 68: 1178-1182. 10.1212\/01.wnl.0000259085.61898.9e.","journal-title":"Neurology"},{"key":"191_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/0140-6736(92)91194-D","volume":"339","author":"AR Jadad","year":"1992","unstructured":"Jadad AR, Carroll D, Glynn CJ, Moore RA, McQuay HJ: Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia. Lancet. 1992, 339: 1367-1371. 10.1016\/0140-6736(92)91194-D.","journal-title":"Lancet"},{"key":"191_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","volume":"311","author":"H McQuay","year":"1995","unstructured":"McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A: Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995, 311: 1047-1052.","journal-title":"BMJ"},{"key":"191_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","volume":"68","author":"HJ McQuay","year":"1996","unstructured":"McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA: A systematic review of antidepressants in neuropathic pain. Pain. 1996, 68: 217-227. 10.1016\/S0304-3959(96)03140-5.","journal-title":"Pain"},{"key":"191_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","volume":"13","author":"N Attal","year":"2006","unstructured":"Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P, EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006, 13: 1153-1169. 10.1111\/j.1468-1331.2006.01511.x.","journal-title":"Eur J Neurol"},{"key":"191_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","volume":"122","author":"GC Hall","year":"2006","unstructured":"Hall GC, Carroll D, Parry D, McQuay HJ: Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006, 122: 156-162. 10.1016\/j.pain.2006.01.030.","journal-title":"Pain"},{"key":"191_CR7","first-page":"519","volume-title":"Health Care Needs Assessment, 3rd series","author":"HJ McQuay","year":"2007","unstructured":"McQuay HJ, Smith LA, Moore RA: Chronic pain. Health Care Needs Assessment, 3rd series. Edited by: Stevens A, Raftery J, Mant J, Simpson S. 2007, Oxford: Radcliffe Publishing, 519-600."},{"key":"191_CR8","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","volume":"293","author":"E Eisenberg","year":"2005","unstructured":"Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA. 2005, 293: 3043-3052. 10.1001\/jama.293.24.3043.","journal-title":"JAMA"},{"key":"191_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","volume":"118","author":"NB Finnerup","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH: Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005, 118: 289-305. 10.1016\/j.pain.2005.08.013.","journal-title":"Pain"},{"key":"191_CR10","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","volume":"2","author":"K Hempenstall","year":"2005","unstructured":"Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS: Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005, 2: e164-10.1371\/journal.pmed.0020164.","journal-title":"PLoS Med"},{"key":"191_CR11","first-page":"CD004846","volume":"2","author":"W Khaliq","year":"2007","unstructured":"Khaliq W, Alam S, Puri N: Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007, 2: CD004846-","journal-title":"Cochrane Database Syst Rev"},{"key":"191_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/bmj.38042.506748.EE","volume":"328","author":"L Mason","year":"2004","unstructured":"Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004, 328: 991-994. 10.1136\/bmj.38042.506748.EE.","journal-title":"BMJ"},{"key":"191_CR13","first-page":"CD005454","volume":"4","author":"T Saarto","year":"2007","unstructured":"Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007, 4: CD005454-","journal-title":"Cochrane Database Syst Rev"},{"key":"191_CR14","first-page":"CD001133","volume":"3","author":"P Wiffen","year":"2005","unstructured":"Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A: Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005, 3: CD001133-","journal-title":"Cochrane Database Syst Rev"},{"key":"191_CR15","first-page":"CD005452","volume":"3","author":"PJ Wiffen","year":"2005","unstructured":"Wiffen PJ, McQuay HJ, Edwards JE, Moore RA: Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005, 3: CD005452-","journal-title":"Cochrane Database Syst Rev"},{"key":"191_CR16","first-page":"CD005451","volume":"3","author":"PJ Wiffen","year":"2005","unstructured":"Wiffen PJ, McQuay HJ, Moore RA: Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005, 3: CD005451-","journal-title":"Cochrane Database Syst Rev"},{"key":"191_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.tips.2004.10.002","volume":"2512","author":"R Suzuki","year":"2004","unstructured":"Suzuki R, Rygh LJ, Dickenson AH: Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci. 2004, 2512: 613-617. 10.1016\/j.tips.2004.10.002.","journal-title":"Trends Pharmacol Sci"},{"key":"191_CR18","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1016\/j.clinthera.2007.12.002","volume":"29","author":"DK Kajdasz","year":"2007","unstructured":"Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar KT, Fishbain DA, Jensen TS, Rowbotham MC, Sang CN, Ziegler D, McQuay HJ: Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther. 2007, 29: 2536-2546. 10.1016\/j.clinthera.2007.12.002.","journal-title":"Clin Ther"},{"key":"191_CR19","unstructured":"Eli Lilly and Company Clinical Trial Registry. [ http:\/\/www.lillytrials.com ]"},{"key":"191_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996, 17: 1-12. 10.1016\/0197-2456(95)00134-4.","journal-title":"Control Clin Trials"},{"key":"191_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0304-3959(00)00234-7","volume":"86","author":"LA Smith","year":"2000","unstructured":"Smith LA, Oldman AD, McQuay HJ, Moore RA: Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain. 2000, 86: 119-132. 10.1016\/S0304-3959(00)00234-7.","journal-title":"Pain"},{"key":"191_CR22","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","volume":"354","author":"D Moher","year":"1999","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet. 1999, 354: 1896-1900. 10.1016\/S0140-6736(99)04149-5.","journal-title":"Lancet"},{"key":"191_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","volume":"78","author":"RA Moore","year":"1998","unstructured":"Moore RA, Gavaghan D, Tram\u00e8r MR, Collins SL, McQuay HJ: Size is everything \u2013 large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 1998, 78: 209-216. 10.1016\/S0304-3959(98)00140-7.","journal-title":"Pain"},{"key":"191_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0304-3959(99)00302-4","volume":"85","author":"DJ Gavaghan","year":"2000","unstructured":"Gavaghan DJ, Moore RA, McQuay HJ: An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data. Pain. 2000, 85: 415-424. 10.1016\/S0304-3959(99)00302-4.","journal-title":"Pain"},{"key":"191_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1258\/1355819021927674","volume":"7","author":"J Higgins","year":"2002","unstructured":"Higgins J, Thompson S, Deeks J, Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy. 2002, 7: 51-61. 10.1258\/1355819021927674.","journal-title":"J Health Serv Res Policy"},{"key":"191_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","volume":"107","author":"KA L'Abbe","year":"1987","unstructured":"L'Abbe KA, Detsky AS, O'Rourke K: Meta-analysis in clinical research. Ann Intern Med. 1987, 107: 224-233.","journal-title":"Ann Intern Med"},{"key":"191_CR27","unstructured":"Morris JA, Gardner MJ: Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. Br Med J (Clin Res Ed). 1995, London: British Medical Journal, 296 (6632): 1313-1316."},{"key":"191_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","volume":"310","author":"RJ Cook","year":"1995","unstructured":"Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995, 310: 452-454.","journal-title":"BMJ"},{"key":"191_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/bmj.315.7109.635","volume":"315","author":"MR Tram\u00e8r","year":"1997","unstructured":"Tram\u00e8r MR, Reynolds DJM, Moore RA, McQuay HJ: Impact of covert duplicate publication on meta-analysis: a case study. BMJ. 1997, 315: 635-639.","journal-title":"BMJ"},{"key":"191_CR30","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004, 50: 2974-2984. 10.1002\/art.20485.","journal-title":"Arthritis Rheum"},{"key":"191_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","volume":"119","author":"LM Arnold","year":"2005","unstructured":"Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005, 119: 5-15. 10.1016\/j.pain.2005.06.031.","journal-title":"Pain"},{"key":"191_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","volume":"116","author":"DJ Goldstein","year":"2005","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005, 116: 109-118. 10.1016\/j.pain.2005.03.029.","journal-title":"Pain"},{"key":"191_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","volume":"6","author":"J Raskin","year":"2005","unstructured":"Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005, 6: 346-356. 10.1111\/j.1526-4637.2005.00061.x.","journal-title":"Pain Med"},{"key":"191_CR34","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","volume":"67","author":"JF Wernicke","year":"2006","unstructured":"Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006, 67: 1411-1420. 10.1212\/01.wnl.0000240225.04000.1a.","journal-title":"Neurology"},{"key":"191_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008, 136: 432-444. 10.1016\/j.pain.2008.02.024.","journal-title":"Pain"},{"key":"191_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpsychires.2004.04.011","volume":"39","author":"SK Brannan","year":"2005","unstructured":"Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF: Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res. 2005, 39: 43-53. 10.1016\/j.jpsychires.2004.04.011.","journal-title":"J Psychiatr Res"},{"key":"191_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4088\/JCP.v65n0411","volume":"65","author":"M Fava","year":"2004","unstructured":"Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM: The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?. J Clin Psychiatry. 2004, 65: 521-530.","journal-title":"J Clin Psychiatry"},{"key":"191_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1176\/appi.psy.45.1.17","volume":"45","author":"DJ Goldstein","year":"2004","unstructured":"Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA: Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics. 2004, 45: 17-28. 10.1176\/appi.psy.45.1.17.","journal-title":"Psychosomatics"},{"key":"191_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1368-5031.2006.00956.x","volume":"60","author":"DG Perahia","year":"2006","unstructured":"Perahia DG, Kajdasz DK, Walker DJ, Raskin J, Tylee A: Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Int J Clin Pract. 2006, 60: 613-620. 10.1111\/j.1368-5031.2006.00956.x.","journal-title":"Int J Clin Pract"},{"key":"191_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","volume":"164","author":"J Raskin","year":"2007","unstructured":"Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC: Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007, 164: 900-909. 10.1176\/appi.ajp.164.6.900.","journal-title":"Am J Psychiatry"},{"key":"191_CR41","volume-title":"Depress Anxiety","author":"JM Russell","year":"2007","unstructured":"Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN: Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Depress Anxiety. 2007, DOI 10.1002\/da20337"},{"key":"191_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198566045.001.0001","volume-title":"Bandolier's Little Book of Making Sense of the Medical Evidence","author":"A Moore","year":"2006","unstructured":"Moore A, McQuay H: Bandolier's Little Book of Making Sense of the Medical Evidence. 2006, Oxford: Oxford University Press"},{"key":"191_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00213-006-0505-1","volume":"188","author":"P Bech","year":"2006","unstructured":"Bech P, Kajdasz DK, Porsdal V: Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder. Psychopharmacology. 2006, 188: 273-280. 10.1007\/s00213-006-0505-1.","journal-title":"Psychopharmacology"},{"key":"191_CR44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1368-5031.2006.00956.x","volume":"60","author":"DG Perahia","year":"2006","unstructured":"Perahia DG, Kajdasz DK, Walker DJ, Raskin J, Tylee A: Duloxetine 60 mg once daily in the treatment of milder major depressive disorder. Int J Clin Pract. 2006, 60: 613-620. 10.1111\/j.1368-5031.2006.00956.x.","journal-title":"Int J Clin Pract"},{"key":"191_CR45","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1742-1241.2007.01476.x","volume":"61","author":"TN Wise","year":"2007","unstructured":"Wise TN, Wiltse CG, Iosifescu DV, Sheridan M, Xu JY, Raskin J: The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity. Int J Clin Pract. 2007, 61: 1283-1293. 10.1111\/j.1742-1241.2007.01476.x.","journal-title":"Int J Clin Pract"},{"key":"191_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1526-4637.2006.00207.x","volume":"7","author":"J Raskin","year":"2006","unstructured":"Raskin J, Wang F, Pritchett YL, Goldstein DJ: Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med. 2006, 7: 373-385. 10.1111\/j.1526-4637.2006.00207.x.","journal-title":"Pain Med"},{"key":"191_CR47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1526-4637.2006.00258.x","volume":"8","author":"JF Wernicke","year":"2007","unstructured":"Wernicke JF, Wang F, Pritchett YL, Smith TR, Raskin J, D'Souza DN, Iyengar S, Chappell AS: An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain. Pain Med. 2007, 8: 503-513. 10.1111\/j.1526-4637.2006.00258.x.","journal-title":"Pain Med"},{"key":"191_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","volume":"30","author":"J Wernicke","year":"2007","unstructured":"Wernicke J, Lled\u00f3 A, Raskin J, Kajdasz DK, Wang F: An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies. Drug Saf. 2007, 30: 437-455. 10.2165\/00002018-200730050-00007.","journal-title":"Drug Saf"},{"key":"191_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000110055","volume":"77","author":"GI Spielmans","year":"2008","unstructured":"Spielmans GI: Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis. Psychother Psychosom. 2008, 77: 12-16. 10.1159\/000110055.","journal-title":"Psychother Psychosom"},{"key":"191_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice AS, Stacey BR, Treede RD, Turk DC, Wallace MS: Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007, 132: 237-251. 10.1016\/j.pain.2007.08.033.","journal-title":"Pain"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-8-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-8-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-8-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,11]],"date-time":"2016-07-11T17:18:19Z","timestamp":1468257499000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-8-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-8-29","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]},"article-number":"29"}}